Chemomab Therapeutics and Scipher Medicine announce merger and concurrent financing

seekingalpha.com

Chemomab Therapeutics and Scipher Medicine have announced a merger agreement. The companies are holding a conference call to discuss the merger, which includes a concurrent financing. Details about the combined company's ownership, leadership, and development plans for Nebokitug are expected.


With a significance score of 2.2, this news ranks in the top 21% of today's 33018 analyzed articles.

Get summaries of news with significance over 5.5 (usually ~10 stories per week). Read by 10,000+ subscribers:


Chemomab Therapeutics and Scipher Medicine announce merger and concurrent financing | News Minimalist